US OptionsDetailed Quotes

MGTX241220P10000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 19 09:30 ET

0.00High0.00Low

MeiraGTx Holdings Stock Discussion

Jaguar8

Oct 22 07:09

NEWS

$MeiraGTx Holdings (MGTX.US)$
MeiraGTx Announces Five Posters at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress
MeiraGTx Holdings plc (Nasdaq: MGTX) announced five poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 2024 Annual Congress in Rome, Italy. The posters highlight the company's advancements in genetic medicine and cell therapy platforms:
1. Optimized AAV manufacturing platform yielding high titers and improved product quality.
2....

Jaguar8

Oct 18 17:23

13G filed after hours. May rally Monday.

$MeiraGTx Holdings (MGTX.US)$

Jaguar8

Oct 18 15:51

NEWS

$MeiraGTx Holdings (MGTX.US)$
MeiraGTx Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Johnson & Johnson(8.6%),Johnson & Johnson Innovation-JJDC, Inc.(8.6%)

mad541

Oct 15 09:11

$Amazon (AMZN.US)$ breaking news big $Meiragtx Holdings Plc just cured Parkinson disease treatment 🔥🔥🔥👀 news today

Stock_Drift

Oct 15 07:07

Pre Market Ticks. 8:05am 10/15

$MeiraGTx Holdings (MGTX.US)$ $ShiftPixy (PIXY.US)$ $Borealis Foods (BRLS.US)$ $NKGEN BIOTECH (NKGN.US)$ $Hoth Therapeutics (HOTH.US)$ $Lipella Pharmaceuticals (LIPO.US)$ $Wolfspeed (WOLF.US)$ $Gritstone Bio (GRTS.US)$ $Banzai International (BNZI.US)$ $Zapata Computing (ZPTA.US)$ $Digital Brands Group (DBGI.US)$

Trytosaveabit

Oct 15 06:17

Update

$MeiraGTx Holdings (MGTX.US)$ Reuters· 3 mins ago
MeiraGTx Holdings PLC: Primary Study Objective of Safety and Tolerability Was Met

Trytosaveabit

Aug 12 06:06

Hmm

$MeiraGTx Holdings (MGTX.US)$ MeiraGTx Announces $50 Million Offering of Ordinary Shares Led by Sanofi’s 30M and Reports Second Quarter 2024 Financial and Operational Results

Jaguar8

Aug 12 06:06

NEWS

$MeiraGTx Holdings (MGTX.US)$
MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi -4/sh
MeiraGTx Holdings plc (Nasdaq: MGTX), a clinical stage genetic medicine company, has announced the pricing of an underwritten offering of 12,500,000 ordinary shares at $4.00 per share. The offering, expected to close on August 13, 2024, aims to raise $50 million in gross proceeds. Sanofi led the financing with a $30 million equity investment, joined by Perceptive Advisors and other inst...

Trytosaveabit

Apr 24 15:34

Wanna see what comes outa these?

$MeiraGTx Holdings (MGTX.US)$ MeiraGTx to Participate in Upcoming Investor Conferences 2 MINUTES AGO, 4:30 PM EDT VIA GLOBENEWSWIRE LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences: Chardan 8th Annual Genetic Medicines ...

Trytosaveabit

Feb 13 07:01

News

$MeiraGTx Holdings (MGTX.US)$ Press Release: MeiraGTx Announces $50 Million Milestone From Janssen Pharmaceuticals
Dow Jones· just

No comment yet